Advertisement

Topics

[News] Gut microbiome and immunotherapy response

23:08 EST 9 Nov 2017 | The Lancet

A new study by Vancheswaran Gopalakrishnan (MD Anderson Cancer Center, Houston, TX, USA) and colleagues has found that the composition of the gut microbiome affects the way patients with advanced melanoma respond to anti-PD-1 immunotherapy.

Original Article: [News] Gut microbiome and immunotherapy response

NEXT ARTICLE

More From BioPortfolio on "[News] Gut microbiome and immunotherapy response"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Skin cancers
There are three main types of skin cancer: basal cell carcinoma, squamous cell carcinoma and malignant melanoma. Basal cell carcinoma Basal cell carcinoma, or BCC, is a cancer of the basal cells at the bottom of the epidermis. It’s very common ...

Immunology
Allergies Automimmune Disease Human Papillomavirus (HPV) Immunology Vaccine Immunology is the study of immunity and the defence mechanisms of the body. A greater understanding of immunology is needed to develop vaccines, understand ...